Business Context and Reporting Period
Company: InspireMD, Inc. (NSPR)
Filing Type: Form 8-K (Current Report)
Date of Report: March 12, 2025
Reporting Period: Fourth quarter and full year ended December 31, 2024
This filing serves as a notification that the company issued a press release on March 12, 2025, detailing its financial and operating results for the specified period. The press release is attached as Exhibit 99.1.
Key Financial Metrics
The provided Form 8-K text does not contain specific numerical data regarding revenue, profit, cash flow, margins, debt, or liquidity. These figures are contained within the referenced press release (Exhibit 99.1) and are not embedded in the body of this filing.
Material Changes
The filing text does not provide specific details on material changes versus prior periods. It only confirms that results for the fourth quarter and year ended December 31, 2024, have been announced.
Guidance, Outlook, and Risks
Management Commentary: The filing references a press release containing recent highlights and results but does not include the commentary text itself.
Legal Disclaimer: In accordance with General Instruction B.2 of Form 8-K, the information furnished under Item 2.02 is not deemed "filed" under the Exchange Act and is not subject to Section 18 liabilities. It will not be incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Review the attached press release (Exhibit 99.1) for specific revenue, net income, and cash flow figures for Q4 and FY 2024.
- Verify any forward-looking statements or guidance provided in the press release, as they are not detailed in this 8-K summary.
- Confirm the company's liquidity position and debt levels from the full financial statements referenced in the press release.
- Check for any unusual items or contingencies disclosed in the full press release text.